Seizert Capital Partners LLC Boosts Stock Position in Centene Co. (NYSE:CNC)

Seizert Capital Partners LLC lifted its stake in shares of Centene Co. (NYSE:CNC) by 6.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 112,141 shares of the company’s stock after buying an additional 6,564 shares during the quarter. Seizert Capital Partners LLC’s holdings in Centene were worth $8,442,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Park Place Capital Corp lifted its holdings in Centene by 1,190.0% during the 3rd quarter. Park Place Capital Corp now owns 387 shares of the company’s stock worth $29,000 after buying an additional 357 shares during the last quarter. WR Wealth Planners LLC boosted its holdings in Centene by 41.4% in the second quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock worth $31,000 after purchasing an additional 137 shares during the period. Chris Bulman Inc acquired a new stake in shares of Centene during the second quarter worth $33,000. Riverview Trust Co boosted its holdings in shares of Centene by 154.6% in the 2nd quarter. Riverview Trust Co now owns 527 shares of the company’s stock valued at $35,000 after buying an additional 320 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. acquired a new stake in Centene during the second quarter worth about $36,000. Institutional investors own 93.63% of the company’s stock.

Centene Stock Performance

CNC opened at $57.46 on Friday. Centene Co. has a fifty-two week low of $57.25 and a fifty-two week high of $81.42. The firm has a market cap of $29.01 billion, a PE ratio of 9.98, a P/E/G ratio of 0.80 and a beta of 0.49. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.64. The business has a fifty day simple moving average of $68.06 and a 200-day simple moving average of $71.00.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft upped their target price on Centene from $82.00 to $87.00 and gave the company a “hold” rating in a report on Friday, August 2nd. StockNews.com downgraded shares of Centene from a “strong-buy” rating to a “buy” rating in a report on Monday, October 28th. Robert W. Baird reduced their target price on shares of Centene from $83.00 to $66.00 and set a “neutral” rating for the company in a research note on Friday, October 25th. Wells Fargo & Company cut their price target on Centene from $91.00 to $90.00 and set an “overweight” rating on the stock in a report on Monday, November 4th. Finally, Jefferies Financial Group lowered Centene from a “buy” rating to a “hold” rating and reduced their price target for the stock from $83.00 to $69.00 in a research report on Wednesday, July 24th. Seven research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat, Centene currently has a consensus rating of “Moderate Buy” and a consensus price target of $83.92.

Insider Buying and Selling

In other Centene news, CFO Andrew Lynn Asher purchased 17,200 shares of the stock in a transaction dated Wednesday, November 13th. The shares were acquired at an average price of $58.14 per share, for a total transaction of $1,000,008.00. Following the completion of the acquisition, the chief financial officer now owns 486,847 shares of the company’s stock, valued at $28,305,284.58. This represents a 3.66 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Sarah London acquired 4,117 shares of Centene stock in a transaction that occurred on Friday, November 8th. The stock was acquired at an average cost of $60.80 per share, with a total value of $250,313.60. Following the completion of the purchase, the chief executive officer now owns 667,229 shares in the company, valued at approximately $40,567,523.20. This represents a 0.62 % increase in their position. The disclosure for this purchase can be found here. 0.33% of the stock is currently owned by company insiders.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.